{"created":"2023-06-19T08:25:36.255771+00:00","id":516,"links":{},"metadata":{"_buckets":{"deposit":"e131d48b-9c57-4051-a703-64308a7abb2e"},"_deposit":{"created_by":18,"id":"516","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"516"},"status":"published"},"_oai":{"id":"oai:hokuriku.repo.nii.ac.jp:00000516","sets":["38:142"]},"author_link":["407","409","410","408"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2006-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"2482","bibliographicPageStart":"2479","bibliographicVolumeNumber":"29","bibliographic_titles":[{"bibliographic_title":"Biological & Pharmaceutical Bulletin"},{"bibliographic_title":"Biological & Pharmaceutical Bulletin","bibliographic_titleLang":"en"}]}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"公益社団法人日本薬学会"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0918-6158","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Higashi, Yasuhiko"},{"creatorName":"Higashi  , Yasuhiko","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"407","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"9000283796528 ","nameIdentifierScheme":"CiNii ID","nameIdentifierURI":"http://ci.nii.ac.jp/nrid/9000283796528 "}]},{"creatorNames":[{"creatorName":"Nakamura, Shota"}],"nameIdentifiers":[{"nameIdentifier":"408","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Fujii, Youichi"},{"creatorName":"Fujii  , Youichi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"409","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"9000283796532 ","nameIdentifierScheme":"CiNii ID","nameIdentifierURI":"http://ci.nii.ac.jp/nrid/9000283796532 "},{"nameIdentifier":"10121287 ","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=10121287 "}]},{"creatorNames":[{"creatorName":"Nakamura  ,  Shota","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"410","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-04-13"}],"displaytype":"detail","filename":"Biological & Pharmaceutical Bulletin　2006.12.pdf","filesize":[{"value":"116.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"Biological & Pharmaceutical Bulletin　2006.12","url":"https://hokuriku.repo.nii.ac.jp/record/516/files/Biological & Pharmaceutical Bulletin　2006.12.pdf"},"version_id":"8a095b91-3494-4edb-9bed-4b552cc37cf2"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"4-(4-bromophenyl)-4-hydroxypoperidine","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"bromperidol","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"derivatization","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"4-fluoro-7-nitro-2,1,3-benzoxadiazole","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"pharmacokinetic study","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"4-Bromophenyl)-4-hydroxypiperidine, a Metabolite of Bromperidol, in Rat Plasma by HPLC with Fluorescence Detection after Pre-column Derivatization Using 4-Fluoro-7-nitro-2,1,3-benzoxadiazole","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"4-Bromophenyl)-4-hydroxypiperidine, a Metabolite of Bromperidol, in Rat Plasma by HPLC with Fluorescence Detection after Pre-column Derivatization Using 4-Fluoro-7-nitro-2,1,3-benzoxadiazole"},{"subitem_title":"4-Bromophenyl)-4-hydroxypiperidine, a Metabolite of Bromperidol, in Rat Plasma by HPLC with Fluorescence Detection after Pre-column Derivatization Using 4-Fluoro-7-nitro-2,1,3-benzoxadiazole","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"18","path":["142"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-04-13"},"publish_date":"2018-04-13","publish_status":"0","recid":"516","relation_version_is_last":true,"title":["4-Bromophenyl)-4-hydroxypiperidine, a Metabolite of Bromperidol, in Rat Plasma by HPLC with Fluorescence Detection after Pre-column Derivatization Using 4-Fluoro-7-nitro-2,1,3-benzoxadiazole"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-06-19T08:34:40.883594+00:00"}